Free Trial

Sernova (SVA) Insider Trading & Ownership

Sernova logo
C$0.24 0.00 (0.00%)
(As of 01:31 PM ET)

Sernova (TSE:SVA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
12.13%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
C$97,671.00
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
C$223,200.00
Get SVA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Sernova stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SVA Insider Buying and Selling by Quarter

Sernova Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/17/2024Steven SanghaDirectorBuy20,000C$0.25C$4,900.00
9/13/2024Steven SanghaDirectorBuy22,600C$0.26C$5,876.00
8/27/2024Steven SanghaDirectorSell930,000C$0.24C$223,200.00
8/15/2024Steven SanghaDirectorBuy100,000C$0.23C$23,000.00
8/6/2024Steven SanghaDirectorBuy100,000C$0.24C$24,000.00
7/30/2024Steven SanghaDirectorBuy35,000C$0.28C$9,625.00
7/22/2024Steven SanghaDirectorBuy11,000C$0.28C$3,080.00
7/19/2024Steven SanghaDirectorBuy51,000C$0.29C$14,790.00
7/15/2024Steven SanghaDirectorBuy40,000C$0.31C$12,400.00
(Data available from 1/1/2013 forward)

SVA Insider Trading Activity - Frequently Asked Questions

The list of insiders at Sernova includes Frank Holler, and Steven Sangha. Learn more on insiders at SVA.

12.13% of Sernova stock is owned by insiders. Learn more on SVA's insider holdings.

The following insider purchased SVA shares in the last 24 months: Steven Sangha (C$97,671.00).

Insiders have purchased a total of 379,600 SVA shares in the last 24 months for a total of C$97,671.00 bought.

The following insider sold SVA shares in the last 24 months: Steven Sangha (C$223,200.00).

Insiders have sold a total of 930,000 Sernova shares in the last 24 months for a total of C$223,200.00 sold.

Sernova Key Executives

  • Dr. Philip M. Toleikis B.A.
    M.Sc., Ph.D., President, CTO, Director of Technology & Director
  • Mr. Christopher Barnes
    Vice President of Investor Relations
  • Dr. Frank Shannon M.D.
    Vice President of Clinical Development & Regulatory Affairs
  • Ms. Cynthia Pussinen
    CEO & Director
  • Mr. Nicholas J. Rossettos CPA (Age 58)
    M.B.A., Interim Chief Financial Officer
  • Mr. Douglas Maret
    Chief Science Officer
  • Dr. Modestus Obochi M.B.A.
    Ph.D., Chief Business Officer


This page (TSE:SVA) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners